TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

PERSONALIZED PRODUCT SUPPORT

A free program to help you every step of the way

OnePath® provides personalized product support to people aged 12 years and older who have been prescribed TAKHZYRO.

Here are just a few ways that OnePath can help:

  • Image of silhouette. Connect with a dedicated Patient Support Manager.

    A dedicated Patient Support Manager

    • A single point of contact who is ready to assist you with your product support needs
  • Image of a dollar sign. Learn about financial assistance options that may be available.

    Financial assistance options

    • Co-pay assistance for those who are eligible,* as well as assistance with navigating insurance coverage
  • Image of a medical clipboard. Receive inhome injection training from a specially trained nurse.

    Injection training

    • In-home training from a specially trained nurse for you and/or a caregiver on how to self-administer TAKHZYRO
  • Image of a computer monitor. Access educational resources, including the free OnePath mobile app.

    Resources and education

    • Connecting you and your caregiver with educational resources

Contact a OnePath Patient Support Manager Monday through Friday, 8:30 am to 8:00 pm ET, at 1–866–888–0660 to learn more.

If you are enrolled in OnePath, you may use the free OnePath Mobile App to connect with OnePath and track your health in a personal eDiary.

*At a minimum to be eligible, patients must have commercial insurance. Other terms and conditions apply. Contact OnePath for more information.

WHAT IS TAKHZYRO?

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.

It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

IMPORTANT SAFETY INFORMATION

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • fast heartbeat
  • faintness
  • rash
  • hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to the FDA at 1–800–FDA–1088.

TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.

Please see full Prescribing Information, including information for patients.